abstract |
The present invention relates to novel uses of 4,17? -Dihydroxyandrost-4-en-3-one (hereinafter referred to as '4-hydroxystestosterone'), To the use of such compounds for the prophylaxis and / or treatment of breast cancer in mammals regardless of the pharmaceutical compositions and / or the estrogen-receptor status of the tumor.n n n n Breast cancer, 4-hydroxysterestone, tumor, estrogen receptor, 4,17? -Dihydroxyandrost-4-en-3- |